These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5486460)

  • 21. Effect of drugs on adrenergic nerve terminals.
    von Euler US
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemical sympathectomy by guanidinium adrenergic neuron blocking agents.
    Johnson EM; Hunter FE
    Biochem Pharmacol; 1979 May; 28(9):1525-31. PubMed ID: 475863
    [No Abstract]   [Full Text] [Related]  

  • 23. Delay by bretylium of adrenergic nerve degeneration after sympathectomy of the submaxillary gland.
    Arbilla S; Perec CJ; Stefano FJ
    Eur J Pharmacol; 1980 Jan; 61(2):147-57. PubMed ID: 7353586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of cocaine, norepinephrine and ionic stimulants on the isolated, superfused rat vas deferens: antagonism by "adrenergic neuron blockers" and reserpine.
    Greenberg S; Long JP
    J Pharmacol Exp Ther; 1971 Apr; 177(1):136-45. PubMed ID: 5566758
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacology of N-[2-(2,6-xylyloxy)ethyl]-guanidine sulphate; an adrenergic neurone blocking agent.
    Barron DI; Natoff IL; Vallance DK
    Br J Pharmacol Chemother; 1965 Oct; 25(2):534-44. PubMed ID: 5866731
    [No Abstract]   [Full Text] [Related]  

  • 26. Concerning the role of the amine pump of the adrenergic innervation of rabbit aorta in sustaining the neuron blockade produced by bethanindine and bretylium.
    Maxwell RA; Eckhardt SB
    Blood Vessels; 1975; 12(3):166-80. PubMed ID: 1164562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The discovery of bretylium and bethanidine.
    Green AF
    Br J Clin Pharmacol; 1982 Jan; 13(1):25-34. PubMed ID: 7066153
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the pharmacology of quaternary derivatives of beta-phenylethylamine].
    Holtz P; Menkens K; Palm D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(2):193-220. PubMed ID: 4385671
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry.
    Malmors T; Abrams WB
    J Pharmacol Exp Ther; 1970 Jul; 174(1):99-110. PubMed ID: 4316536
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and adrenergic neuron blocking properties of some alkylating analogues of bretylium.
    Krueger CA; Cook DA
    Arch Int Pharmacodyn Ther; 1975 Nov; 218(1):96-105. PubMed ID: 1212016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of 4,4'-biphenylenebis-((2-oxoethylene)-bis-(2,2-diethoxyethyl))dimethylammonium dibromide (DMAE) on the responses of tissues innervated by short adrenergic neurons to catecholamines and ionic stimulants.
    Greenberg S; Long JP; Diecke FP
    J Pharmacol Exp Ther; 1971 Nov; 179(2):161-70. PubMed ID: 4332323
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neurochemical mechanisms of artifical hypobiosis and chemical thermoregulation].
    Timofeev NN; Konstantinov GA
    Fiziol Zh SSSR Im I M Sechenova; 1985 Sep; 71(9):1145-50. PubMed ID: 4054399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the mechanism of action of new drugs effective upon the autonomic and central nervous system].
    Oberdorf A; Hoffmeister F; Kroneberg G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):48-9. PubMed ID: 4231861
    [No Abstract]   [Full Text] [Related]  

  • 34. THE PHARMACOLOGY OF NEW ADRENERGIC NEURONE BLOCKING AGENTS, N-P-CYCLOHEXYLBENZYLTROPINIUM DERIVATIVES.
    DODA M; FEHER O; GYOERGY L; NADOR K
    Br J Pharmacol Chemother; 1963 Aug; 21(1):10-26. PubMed ID: 14066135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of beta-TM 10 on the pharmacological, biochemical and morphological changes induced by denervation of the nictitating membrane in the cat.
    Pluchino S; Van Orden LS; Draskóczy PR; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1970 Mar; 172(1):77-90. PubMed ID: 5416947
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of antiadrenergic compounds on phosphorylase activity in the rat liver during exposure to extremely strong stimulation].
    Korkhov VV
    Farmakol Toksikol; 1969; 32(4):393-6. PubMed ID: 4391078
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of new guanidine derivatives on adrenergic nerve endings, ganglionic transmission and neuromuscular junction.
    Kadzielawa K; Gumulka W
    Act Nerv Super (Praha); 1965 Aug; 7(3):278-9. PubMed ID: 4222712
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of bretylium on rat cardiac muscle: the electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts.
    Namm DH; Wang CM; El-Sayad S; Copp FC; Maxwell RA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):194-208. PubMed ID: 1133764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ornid but not atropine abolishes the insulin receptor reaction of fat and liver plasma membranes to fasting and hyperinsulinemia].
    Bezdrobnyĭ IuV; Evdokimova NIu
    Fiziol Zh SSSR Im I M Sechenova; 1984 Feb; 70(2):200-5. PubMed ID: 6370738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs.
    Mitchell JR; Oates JA
    J Pharmacol Exp Ther; 1970 Mar; 172(1):100-7. PubMed ID: 5416937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.